# Granisetron Hcl (Granisol)

Source: https://ourhealthnetwork.com/drugs/granisetron-hcl
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Granisetron Hcl?

Granisetron Hcl (brand name: Granisol) is a 5-ht3 receptor antagonists. It is prescribed to treat prevent nausea and vomiting caused by cancer chemotherapy and to prevent and treat nausea and vomiting that may occur after surgery. Across the United States, 110 doctors prescribe Granisetron to approximately 1,000 Medicare patients.

## Brand names

Granisol

## Indications

Granisetron Hcl is primarily prescribed for the treatment of prevent nausea and vomiting caused by cancer chemotherapy and to prevent and treat nausea and vomiting that may occur after surgery.

## Conditions treated

- [Chemotherapy-Induced Nausea and Vomiting](https://ourhealthnetwork.com/conditions/chemotherapy-induced-nausea-and-vomiting)
- [Postoperative Nausea and Vomiting](https://ourhealthnetwork.com/conditions/postoperative-nausea-and-vomiting)

## Mechanism of action

blocking serotonin, a natural substance in the body that causes nausea and vomiting

## Drug classification

- Established Pharmacologic Class: 5-HT3 receptor antagonists
- Route of administration: ORAL

## Common side effects

alopecia, and vomiting, anemia, anxiety, decreased appetite, dizziness, fever, hypertension

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)
